The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver

Toxicology

Volumn 239, Issue 1-2, 2007, Pages 127-135

  Kostka, Grazyna ^a   Urbanek, Katarzyna ^a   Ludwicki, Jan K ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

DNA methylation; DNA methyltransferase; DNA synthesis; Liver; p16; Phenobarbital

Indexed keywords

DNA METHYLTRANSFERASE; PHENOBARBITAL; PROTEIN P16;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SYNTHESIS; ENZYME ACTIVITY; GENE REPRESSION; HEPATOMEGALY; LIVER; LIVER WEIGHT; MALE; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; TUMOR PROMOTION;

ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; CARCINOGENS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA REPLICATION; GENES, P16; LIVER; MALE; ORGAN SIZE; PHENOBARBITAL; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 34548027289     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.07.003     Document Type: Article

References (54)

1. Adams R.L.P., Rinaldi A., and Seivwright C. Microassay for DNA methyltransferase. J. Biochem. Biophys. Methods 22 (1991) 19-22
2. Amacher D.E., Beck R., Schomaker S.J., and Kenny C.V. Hepatic microsomal enzyme induction, β-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat. Toxicol. Appl. Pharmacol. 142 (1997) 143-150
3. Ashby J. Use of short-term tests in determining the genotoxicity of non-genotoxicity of chemicals. In: Vainio H., Magee P.N., McGregor D.B., and McMichael A.J. (Eds). Mechanisms of Carcinogenesis in Risk Identification vol. 116 (1992), International Agency for Research on Cancer, Lyon 135-164
4. Bachman A.N., Phillips J.M., and Goodman J.I. Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prome B6C3F1 mice. Toxicol. Sci. 91 (2006) 393-405
5. Ballestar E., and Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23 (2002) 1103-1109
6. Barrass N.C., Price R.J., Lake B.G., and Orton T.C. Comparison of the acute and chronic mitogen effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis 14 (1993) 1451-1456
7. Belinsky S.A. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26 (2005) 1481-1487
8. INK 4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11891-11896
9. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9 (2000) 2395-2402
10. Biniszkiewicz D., Gribnau J., Ramsahoye B., Gaudet F., Eggan K., Humpherys D., Mastrangelo M.A., Jun Z., Walter J., and Jaenisch R. Dnmt 1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol. Cell. Biol. 22 (2002) 2124-2135
11. Bombail V., Moggs J.G., and Orphanides G. Perturbation of epigenetic status by toxicants. Toxicol. Lett. 149 (2004) 51-58
12. Burton K.A. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62 (1956) 315-323
13. Carthew P., Edwards R.E., and Nolan B.M. The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Toxicol. Sci. 44 (1998) 46-51
14. Coffin J.C., Ge R., Yang S., Kramer P.M., Tao L., and Pereira M.A. Effect of trihalomethanes on cell proliferation and DNA methylation in female B6C3F1 mouse liver. Toxicol. Sci. 58 (2000) 243-252
15. Cohen S.M., and Ellwein L.B. Cell proliferation in carcinogenesis. Science 51 (1990) 6493-6505
16. Counts J.I., Sarmiento J.I., Harbison M.I., Downing J.C., McClain R.M., and Goodman J.I. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis 17 (1996) 1251-1257
17. Eacho P.I., Lanier T.C., and Brodhecker C.A. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of Wyeth-14,643 to clofibric acid, nafenopin and LY 171883. Carcinogenesis 12 (1991) 1557-1561
18. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61 (2001) 3225-3229
19. Fatemi H., Hermann A., Gowher H., and Jeltsch A. Dnmt 3a and Dnmt 1 functionally cooperate during de novo methylation of DNA. Eur. J. Biochem. 269 (2002) 4981-4984
20. Gardiner-Garden M., and Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196 (1987) 261-283
21. Ge R., Wang W., Kramer P.M., Yang S., Tao L., and Pereira M.A. Wy-14,643-induced hypomethylation of the c-myc gene in mouse liver. Toxicol. Sci. 62 (2001) 28-35
22. Ge R., Tao L., Kramer P.M., Cunningham M.L., and Pereira M.A. Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver. J. Biochem. Mol. Toxicol. 16 (2002) 1-7
23. Goodman J.I., and Watson R.F. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 501-525
24. Grasl-Kraupp B., Luebeck G., Wagner A., Lo{combining double acute accent}w-Baselli A., de Gunst M., Waldho{combining double acute accent}r T., Moolgavkar S., and Schulte-Hermann R. Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 21 (2000) 1411-1421
25. Hsieh C.L. The de novo methylation activity of Dnmt 3a is distinctly different than that of Dnmt 1. BMC Biochem. 6 (2005) 6
26. IARC, 2001. IARC Monographs on the evaluation of carcinogenic Risks to Humans. Some Thyrotropic Agents, vol. 79. International Agency for Research on Cancer, Lyon, pp. 161-289.
27. Jones H.B., and Clarke N.A.B. Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in rat using bromodeoxyuridine immunocytochrmistry. Arch. Toxicol. 67 (1993) 622-628
28. Kolaja K.L., Stevenson D.E., Walborg Jr. E.F., and Klaunig J.E. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17 (1996) 947-954
29. Kostka G., Kopeć-Szle{ogonek}zak J., and Palut D. Early hepatic changes induced by nuarimol in rats. J. Appl. Toxicol. 14 (1994) 337-342
30. Kostka G., Palut D., Ludwicki J.K., Kopeć-Szle{ogonek}zak J., Wiadrowska B., and Lembowicz K. Hepatocellular peroxisome proliferation and DNA synthesis in Wistar rats treated with herbicide fluazifop. Toxicology 178 (2002) 221-228
31. Liang G., Chan M.F., Tomigahana Y., Tsai Y.C., Gonzales F.A., Li E., Laird P.W., and Jones P.A. Cooperativity between DNA methyltransferases in the maintenance methylation of replicative elements. Mol. Cell. Biol. 22 (2002) 480-491
32. Lindroos P., Tsai W.H., Zarnegar R., and Michalopoulos G.K. Plasma levels of HGF in rats treated with tumor promoters. Carcinogenesis 13 (1992) 139-141
33. Novik K.L., Nimmrich I., Genc B., Maier S., Piepenbrock C., Olek A., and Beck S. Epigenomics: genome-wide study of methylation phenomena. Curr. Issues Mol. Biol. 4 (2002) 111-128
34. Okano M., Bell D.W., Haber D.A., and Li E. DNA methyltransferases: Dnmt 3a and Dnmt 3b are essential for de novo methylation and mammalian development. Cell 99 (1999) 247-257
35. Pereira M.A., Kramer P.M., Conran P.B., and Tao L. Effect of chloroform on dichloroacetic and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice. Carcinogenesis 22 (2001) 1511-1519
36. Plant N.J., Horley N.J., Dickins M., Hasmall S., Elcombe C.R., and Bell D.R. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis 19 (1998) 1521-1527
37. Pogribny I.P., and James S.J. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett. 176 (2002) 169-174
38. Reik W., Dean W., and Walter J. Epigenetic reprogramming in mammalian development. Science 293 (2001) 1089-1093
39. Roberts R.A., Nebert D.W., Hickman J.A., Richburg J.H., and Goldsworthy T.L. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38 (1997) 107-115
40. Schulte-Hermann R. Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism. Arch. Toxicol. 2 (1979) 113-124
41. Schulte-Hermann R., Bursch W., Grasl-Kraupp B., Torok L., Ellinger A., and Mullauer L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol. Lett. 82/83 (1995) 143-148
42. Schulte-Hermann R., Bursch W., Marian B., and Grasl-Kraupp B. Active Cell Death (Apoptosis) and Cellular Proliferation as Indicators of Exposure to Carcinogens vol. 146 (1999), IARC Sci. Publ., Lyon pp. 273-285
43. Schulte-Hermann R., Timmermann-Trosiener I., Barthel G., and Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50 (1990) 5127-5135
44. Smith P.F., O'Brien K.A., and Keenan K.P. Evaluation of bromodeoxyuridine labeling in hepatomegaly produced by peroxisomal proliferation or P-450 induction in rodents. Prog. Clin. Biol. Res. 369 (1991) 285-289
45. Tanaka K., Smith P.F., and Stronberg C. Studies of early hepatocellular proliferation and peroximal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol. Appl. Pharmacol. 116 (1992) 71-77
46. Tao L., Wang W., Li L., Krammer P.M., and Pereira M.A. Effect of dibromoacetic acid on DNA methylation, glycogen accumulation and peroxisome proliferation in mouse and rat liver. Toxicol. Sci. 82 (2004) 62-69
47. Tao L., Yang S., Xie M., Kramer M.P., and Pereira M.A. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett. 158 (2000) 185-193
48. Wada N., Marsman D.S., and Popp J.A. Dose-related effects of the hepatocarcinogen, WY-14,643 on peroxisomes and cell replication. Fundam. Appl. Toxicol. 18 (1992) 149-154
49. Watson R.E., and Goodman J.I. Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit different levels of susceptibility to liver tumorigenesis. Toxicol. Sci. 68 (2002) 51-58
50. Watson R.E., Curtin G.M., Doolittle D.J., and Goodman J.I. Progressive alterations in global and GC-rich DNA methylation during tumorigenesis. Toxicol. Sci. 75 (2003) 289-299
51. Williams G.M., and Iatropoulos M.J. Altered of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol. Pathol. 30 (2002) 41-53
52. Wong I.H.N., Lo Y.M.D., Zhang J., Liew C., Ng M.H.L., Wong N., Lai P.B.S., Lau W.Y., Hjelm M., and Johnson P.J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59 (1999) 71-73
53. Yamasaki H., Ashiby J., Bignami M., Jongen W., Linnainma K., Newbold R.F., Nguyen-Ba G., Porodi S., Rivedal E., Schiffmann D., Simons J.W.I.M., and Vasseur P. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat. Res. 353 (1996) 47-63
54. Yoshikawa K. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens. Environ. Health Persp. 104 (1996) 40-46